Soraia Fernandes*, Marco Cassani, Stefania Pagliari, Petr Filipensky, Francesca Cavalieri and Giancarlo Forte* Pages 7234 - 7255 ( 22 )
Nanodrugs represent novel solutions to reshuffle repurposed drugs for cancer therapy. They might offer different therapeutic options by combining targeted drug delivery and imaging in unique platforms. Such nanomaterials are deemed to overcome the limitations of currently available treatments, ultimately improving patients’ life quality. However, despite these promises being made for over three decades, the poor clinical translation of nanoparticle- based therapies calls for deeper in vitro and in vivo investigations. Translational issues arise very early during the development of nanodrugs, where complex and more reliable cell models are often replaced by easily accessible and convenient 2D monocultures. This is particularly true in the field of cancer therapy. In fact, 2D monocultures provide poor information about the real impact of the nanodrugs in a complex living organism, especially given the poor mimicry of the solid Tumors Microenvironment (TME). The dense and complex extracellular matrix (ECM) of solid tumors dramatically restricts nanoparticles efficacy, impairing the successful implementation of nanodrugs in medical applications. Herein, we propose a comprehensive guideline of the 3D cell culture models currently available, including their potential and limitations for the evaluation of nanodrugs activity. Advanced culture techniques, more closely resembling the physiological conditions of the TME, might give a better prediction of the reciprocal interactions between cells and nanoparticles and eventually help reconsider the use of old drugs for new applications.
Nanodrugs, drug delivery, nanomedicine, tumor, 3D in vitro cell models, physiological conditions.
International Clinical Research Center (ICRC) of St Anne’s University Hospital, CZ-65691 Brno, International Clinical Research Center (ICRC) of St Anne’s University Hospital, CZ-65691 Brno, International Clinical Research Center (ICRC) of St Anne’s University Hospital, CZ-65691 Brno, St Anne’s University Hospital, CZ-65691 Brno, School of Science, RMIT University, Melbourne, VIC, International Clinical Research Center (ICRC) of St Anne’s University Hospital, CZ-65691 Brno